Oral Abstract Session 1: Allergen Immunotherapy 1

Monday, 5 December 2011: 12:45 - 14:15
Gran Cancún 1 (Cancún Center)
Chairpersons:   Noel Rodriguez-Perez (Mexico) and Enrico Compalati (Italy)
12:45 - 13:00
2156: Ultra-Rush Specific Immune Therapy with Depigmented and Polymerized Allergen Extracts Is Effective and Safe in Patients with Severe SAR Highly Sensitized Against Pollen Allergens Ulrich Amon (Germany)
13:00 - 13:15
2157: Dose Optimizing Study of A Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test | Angelika Sager (Germany)
13:15 - 13:30
2158: Double-Blind Study on The Use of Transfer Factor (TF) Combined With Sublingual Immunotherapy in Management of Patients With Allergic Rhinitis in Mexican Population | María Isabel Rojo Gutiérrez (Mexico)
13:30 - 13:45
2159: The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults when Treated With Standardised Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials | Jens Strodl Andersen (Denmark)
13:45 - 14:00
2160: Post-treatment, long-term clinical efficacy of a 300 IR sublingual tablet of 5-grass pollen allergen extract in adults with grass pollen-induced allergic rhinoconjunctivitis Michčle Lheritier-Barrand (France)
14:00 - 14:15
2161: Escherichia coli Heat-labile Enterotoxin (LTS61K) Modulates Dendritic Cell Function and Attenuates Airway Inflammation in Mouse Model of Allergic Asthma | Jiu_yao Wang (Taiwan)
See more of: Oral Abstract Session
See more of: Abstract Presentations
<< Previous Session | Next Session >>